StockSelector.com
  Research, Select, & Monitor Friday, August 18, 2017 12:27:46 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Bristol-Myers Squibb Co.$56.78$.01.02%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Bristol-Myers Squibb Co. has an overall rank of 816 out of 6890 stocks based on 15 positive rankings and 8 negative rankings.

Positive Rankings
Highest ROA
Bristol-Myers Squibb Co. rank is 306
Top Intrinsic Values
Bristol-Myers Squibb Co. rank is 372
Highest ROE
Bristol-Myers Squibb Co. rank is 384
Highest Net Margin
Bristol-Myers Squibb Co. rank is 505
PEGValue
Bristol-Myers Squibb Co. has a PEG Value of $64.82. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 14.18% in the next year. Among companies with a PEG Value above the current stock price, Bristol-Myers Squibb Co. is ranked 559.
10 Day Gain
Bristol-Myers Squibb Co. rank is 661
SSValue
The StockSelector Value for Bristol-Myers Squibb Co. is $88.04. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Bristol-Myers Squibb Co. is ranked 713.
Top Industry Values
Bristol-Myers Squibb Co. rank is 836
Low Put/Call
Bristol-Myers Squibb Co. has a low Put/Call ratio of 0.42 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 1043.
Estimated EPS Growth
Bristol-Myers Squibb Co. rank is 1111
90 Day Gain
Bristol-Myers Squibb Co. rank is 1314
Historic EPS Growth
Bristol-Myers Squibb Co. rank is 1418
Estimated Revenue Growth
Bristol-Myers Squibb Co. rank is 1695
Debt-to-Equity
Bristol-Myers Squibb Co. rank is 2084
Up EPS Surprise
Bristol-Myers Squibb Co. beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Missed Whisper
According to EarningsWhispers.com, Bristol-Myers Squibb Co. missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative Stoch Cross
Bristol-Myers Squibb Co. rank is 257
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Bristol-Myers Squibb Co. is ranked 328.
Price-to-Book
Bristol-Myers Squibb Co. rank is 696
Price-to-Sales
Bristol-Myers Squibb Co. rank is 1112
Negative Revenue Growth
Bristol-Myers Squibb Co. rank is 1236
Negative Cash Growth
Bristol-Myers Squibb Co. rank is 1412
High vPut/Call
Bristol-Myers Squibb Co. has a high Put/Call ratio of 0.52 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Bristol-Myers Squibb Co. is ranked 2091.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.